Aktienkurs
114.97
Täglich Wechseln
1.14 1.00%
Monatlich
-2.74%
Jährlich
-26.14%
Q2 Prognose
114.37




Aktuelle Verpflichtungen Veränderung Datum
AbbVie USD 43.29B 3.9B 2025-12
Align Technology USD 1.91B 14.16M 2026-03
Bayer EUR 32.58B 3.63B 2025-12
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Charles River Laboratories USD 1.12B 1.57M 2025-12
Coherus Biosciences USD 140.39M 231.91M 2025-12
Dentsply International USD 1.34B 62M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Henry Schein USD 3.23B 79M 2025-12
Idexx Laboratories USD 1.15B 103M 2025-12
Illumina USD 1.59B 377M 2025-12
IQVIA Holdings USD 8.34B 170M 2025-12
J&J USD 57.72B 3.59B 2026-03
Laboratory Of America USD 2.82B 194.3M 2025-12
Merck USD 28.33B 301M 2025-12
Neogen USD 150.6M 3.55M 2025-12
Pacira USD 108.79M 11.8M 2026-03
Perrigo USD 1.01B 132.4M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Phibro Animal Health USD 282.37M 12.23M 2025-12
Quest Diagnostics USD 2.18B 101M 2026-03
Sanofi EUR 30.01B 1.66B 2026-03
Sanofi EUR 28.35B 9.32B 2025-12
Zoetis USD 2.24B 428M 2025-12